Pharmacokinetics of Molnupiravir in Cats with Naturally Occurring Feline Infectious Peritonitis
Pathogens · 2025
DOI: 10.3390/pathogens14070666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Petra Černá und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA. Hauptthemen laut MEDLINE: Cytidine, Antiviral Agents, Feline Infectious Peritonitis, Hydroxylamines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EveryCat Health Foundation.
Abstract (Originalsprache)
Antiviral drugs like EIDD-2801 (molnupiravir; MPV) have been successfully used in the treatment of feline infectious peritonitis (FIP). The previous study of the pharmacokinetics of MPV in healthy cats showed promise for its use and safety. The objective was to determine the pharmacokinetics of molnupiravir in cats with naturally occurring FIP by measuring MPV and EIDD-193 (β-D-N4-hydroxycytidine; NHC) serum levels. Blood was collected from seven cats diagnosed with naturally occurring FIP treated at 1, 2, 4, 6 and 12 h post oral MPV administration and at 12 h post pill administration 7 days later. Serum concentrations of MPV and NHC were determined using a previously published high-performance liquid chromatography–tandem mass spectrometry (HPLC-MS/MS) method. The mean dose of MPV was 15.44 mg/kg (SD ± 1.82). The mean peak serum concentration of MPV (Cmax) after a single PO dose of MPV was 38 ng/mL (SD ± 5). The mean peak serum concentration of NHC (Cmax) after a single PO dose of MVP was 1551 ng/mL (SD ± 720). the time to reach NHC Cmax (Tmax) was 2.6 h (SD ± 1.4), and the NHC elimination half-life was 1.6 h (SD ± 1.1). Minimal drug accumulation was seen in trough concentrations following twice-daily dosing for 7 days. The low MPV levels may be explained by fast conversion to its active metabolite NHC. The mean NHC concentrations at all time points were at least 4 times the reported in vitro IC50 for feline coronavirus strains and twice-daily dosing for seven days did not lead to drug accumulation within the serum. The results support the use of MPV in the treatment of FIP, and if therapeutic drug monitoring is to be performed, NHC should be measured.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
- Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USA.
ORCID-Profile: Petra Černá
Förderung
- EveryCat Health Foundation
Zitieren
APA
Černá, P., Wittenburg, L., Hawley, J., Willis, M., Siegenthaler, B., & Lappin, M. R. (2025). Pharmacokinetics of Molnupiravir in Cats with Naturally Occurring Feline Infectious Peritonitis. Pathogens. https://doi.org/10.3390/pathogens14070666
Vancouver
Černá P, Wittenburg L, Hawley J, Willis M, Siegenthaler B, Lappin MR. Pharmacokinetics of Molnupiravir in Cats with Naturally Occurring Feline Infectious Peritonitis. Pathogens. 2025. doi:10.3390/pathogens14070666
BibTeX
@article{ern2025,
author = {Černá, Petra and Wittenburg, Luke and Hawley, Jennifer and Willis, McKenna and Siegenthaler, Britta and Lappin, Michael R},
title = {Pharmacokinetics of Molnupiravir in Cats with Naturally Occurring Feline Infectious Peritonitis},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14070666}
}
EUVIMED